Allen Wolff Brooklyn Immuno Therapeutics, Inc. (BTX) insider trading activity

Allen Wolff is Former Director and CEO of Brooklyn ImmunoTherapeutics, Inc.. Currently has a direct ownership of 128,520 shares of BTX, which is worth approximately $0. The most recent transaction as insider was on Mar 24, 2021, when has been sold 9,944 shares (Common Stock) at a price of $2.67 per share, resulting in proceeds of $26,550. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 129K

0% 3M change

0% 12M change

Total Value Held $0

Allen Wolff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 24 2021	SELL Payment of exercise price or tax liability	$26,550 $2.67 p/Share	9,944 Reduced 7.18%	128,520 Common Stock
Mar 19 2021	SELL Payment of exercise price or tax liability	$731 $3.53 p/Share	207 Reduced 0.15%	138,464 Common Stock
Feb 19 2021	SELL Payment of exercise price or tax liability	$996 $4.81 p/Share	207 Reduced 0.15%	138,671 Common Stock
Jan 19 2021	SELL Payment of exercise price or tax liability	$7,617 $2.55 p/Share	2,987 Reduced 2.11%	138,878 Common Stock
Dec 19 2020	SELL Payment of exercise price or tax liability	$369 $2.17 p/Share	170 Reduced 0.12%	141,865 Common Stock
Nov 20 2020	SELL Payment of exercise price or tax liability	$320 $1.88 p/Share	170 Reduced 0.12%	142,035 Common Stock
Oct 21 2020	SELL Payment of exercise price or tax liability	$5,029 $2.05 p/Share	2,453 Reduced 1.7%	142,205 Common Stock

Allen Wolff

Former Director and CEO

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTX shares.

Notify only if

Value

Insider Trading

Get notified when an Brooklyn Immuno Therapeutics, Inc. insider buys or sells BTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Brooklyn ImmunoTherapeutics, Inc.

Track Activities on BTX

Account